En Es
Categories

Industry News

GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform

By Labmedica International staff writers
16 Jan 2018

Image: GE Healthcare and Roche have entered into a partnership to jointly develop and co-market digital clinical decision support solutions (Photo courtesy of iStock).GE Healthcare (Chicago, IL, USA) and Roche (Basel, Switzerland) have entered into a strategic, long-term partnership to jointly develop and co-market digital clinical decision support solutions. Initially, the partnership will focus on products that accelerate and improve individualized treatment options for cancer and critical care patients.

GE Healthcare is a leading provider of medical imaging equipment, harnessing data and analytics across hardware, software and biotech. Roche is a pioneer in pharmaceuticals and diagnostics, and is the world’s largest biotech company, offering differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. The company is also a leader in the fields of in vitro diagnostics and tissue-based cancer diagnostics, and is a frontrunner in diabetes management.

Together, the companies will focus on developing the first digital platform in the industry, using advanced analytics to provide workflow solutions and apps that support clinical decisions. This will enable seamless integration and analysis of in-vivo and in-vitro data, patient records, medical best practice, real time monitoring and the latest research outcomes. This will also provide comprehensive decision support to clinicians for offering the right treatment and quality of care for their patients.

For instance, oncology care teams with multiple specialists will be able to access a comprehensive data dashboard to review, collaborate and align on treatment decisions for cancer patients at each stage of their disease. Similarly, in the critical care setting, data from a patient’s hospital monitoring equipment will be integrated with their biomarker, genomic and sequencing data to help physicians identify, or even predict severe complications before they arise.

“This unique partnership will deliver innovative solutions and insights in clinical decision-making,” said Roland Diggelmann, CEO Roche Diagnostics. “Our goal is to support clinicians and other relevant stakeholders for the benefit of patients by providing the right decision support at the right time and through comprehensive digital offerings.”

“This is the first time that two major players in healthcare have combined digital, in-vivo and in-vitro diagnostics to this degree,” said Kieran Murphy, President and CEO of GE Healthcare. “We believe this alliance will help accelerate the delivery of data-driven precision health for customers, patients and the healthcare industry.”



E-mail Print
FaceBook Twitter Google+ Linked in

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services. The company’s product areas include anesthesia delivery, diagnostic ECG, mammography, radiography, surgical imaging, maternal-infant care and clinical consumables.
More info

More articles about GE Healthcare

18 Oct 2018
GE Healthcare and ESR Enter AI Partnership for ECR 2019
GE Healthcare (Chicago, IL, USA) and the European Society of Radiology (Vienna, Austria) will be partnering on artificial intelligence (AI) for the upcoming European Congress of Radiology (ECR) to be held in Vienna, Austria on February 27-March 3, 2019. The partnership will include joint sessions on AI and a dedicated space at GE Healthcare’s booth where visitors will be able to experience the AI transformation through interactive tools.
Read More
15 Oct 2018
GE Healthcare to Implement First AI-Powered Hospital Command Centers
GE Healthcare is collaborating with hospital service providers in Europe and the US for implementing an artificial intelligence (AI)-powered command center to effectively and efficiently synchronize all elements of a patient's hospital experience. The AI-powered system will support caregivers to enhance patient safety, orchestrate seamless care delivery and get patients back home sooner.
Read More
26 Jun 2018
GE to Spin Off Healthcare Business
In line with a sweeping strategic reorganization, General Electric Company has announced the decision to spin off its Healthcare business segment as an independent company. The move comes on the heels of a lengthy managerial review conducted by GE management under newly appointed CEO John Flannery.
Read More
06 Dec 2017
GE Healthcare and Nuance Partner with NVIDIA to Bring AI to Medical Imaging
Healthcare-solution providers GE Healthcare and Nuance Communications, Inc., have partnered with NVIDIA, a leader in visual computing technologies, for using the company’s deep learning platform to bring Artificial Intelligence (AI) to medical imaging.
Read More
05 Dec 2017
GE Launches Drawbridge Health to Transform Blood Collection
GE Healthcare has introduced Drawbridge Health, a privately held healthcare technology company, which is developing a people-friendly system to integrate draw, collection and stabilize blood samples into a single device. The technology which integrates engineering and proprietary chemistries is also being developed to support room temperature shipping and streamlined downstream processing, thus ensuring reliable, accurate results.
Read More
28 Nov 2017
Global Surgical Imaging Market to Reach USD 1.63 Billion by 2022
The global surgical imaging market is projected to grow at a CAGR of 5.5% from an estimated value of USD 1.25 billion in 2017 to USD 1.63 billion by 2022, driven mainly by the growing popularity of Flat Panel Detector C-arms (FPD C-arms) owing to the advantages of FPDs over image intensifiers, reimbursement cuts on analog radiography systems, and rising demand for minimally invasive procedures.
Read More
28 Nov 2017
GE Healthcare and DiA Imaging Analysis to Develop Machine Learning Algorithms
GE Healthcare has entered into a multi-year, non-exclusive licensing and professional services agreement with DiA Imaging Analysis, a medical imaging analysis software company, for developing automated imaging analysis technology to work with its ultrasound devices.
Read More
16 Oct 2017
Handheld Scanners Market to Reach USD 725 Million by 2027
The global handheld ultrasound scanners market is projected to grow at a robust CAGR of 8.8% from around USD 311 million in 2017 to about USD 725 million by 2027 end, driven mainly by the increasing use of handheld ultrasound scanners among non-radiologists and modernization in healthcare, coupled with high investment in research and development (R&D).
Read More

Additional news

24 Apr 2019
New AI System Performs As Well As Radiologists in Detecting Prostate Cancer
Researchers from the University of California have developed a new artificial intelligence (AI) system to help radiologists improve their ability to diagnose prostate cancer.
Read More
24 Apr 2019
New Roadmap Outlines AI Research Priorities for Medical Imaging
A report establishing a research roadmap outlining priorities in foundational and translational research in artificial intelligence (AI) for medical imaging has been published in the journal Radiology.
Read More
18 Apr 2019
AI Algorithm Detects Breast Cancer in MR Images
A team of researchers from Memorial Sloan Kettering Cancer Center have trained a smart algorithm on a neural network to recognize the appearance of breast cancer in MR images.
Read More
18 Apr 2019
Wireless Syringe Pumps a Key Trend in Global Syringe Pump Market
The global smart syringe pumps market is projected to grow at a CAGR of close to 9% during the forecast period 2019-2023, driven primarily by the increased demand for refurbished syringe pumps among end-users and the development of wireless smart syringe pumps.
Read More
18 Apr 2019
Global Automated Immunoassay Analyzer Market Driven by Increase in Applications
The global automated immunoassay analyzer market is expected to achieve significant growth over the coming years, driven by innovations in the existing products and increased clinical applications of these systems.
Read More
18 Apr 2019
Global Mammography Market Driven by Increased Breast Cancer Prevalence
The growth of the global mammography market is being driven by the rising prevalence of breast cancer, technological advancements in breast imaging, and investments by various organizations in breast cancer screening campaigns.
Read More
16 Apr 2019
FDA Approves First AI-Powered Radiation Exposure Reduction Solution
An artificial intelligence (AI) powered region of interest (ROI) radiation exposure reduction solution for interventional X-ray imaging has received clearance from the US FDA.
Read More
16 Apr 2019
FDA Developing Regulatory Framework for AI-Related Medical Devices
The US Food and Drug Administration is considering a new regulatory framework specifically tailored to promote the development of safe and effective medical devices that use advanced artificial intelligence (AI) algorithms.
Read More
16 Apr 2019
Global Multi-Parameter Patient Monitoring Market to Reach USD 6 Billion by 2028
The global multi-parameter patient monitoring market is expected to grow moderately at a CAGR of 4.6% over the 2018-2028 projected period to reach USD 6 billion by the end of 2028, driven mainly by rising affluence in the emerging markets and the increasing aging population in developed economies providing a boost to healthcare spending.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions